Browse by Glasgow Author (original) (raw)

Number of items: 6.

2024

Scott, M. T. et al. (2024)Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease. Nature Communications, 15, 651. (doi: 10.1038/s41467-024-44771-9) (PMID:38246924) (PMCID:PMC10800356)

2019

Baquero, P. et al. (2019)Targeting quiescent leukemic stem cells using second generation autophagy inhibitors. Leukemia, 33(4), pp. 981-994. (doi: 10.1038/s41375-018-0252-4) (PMID:30185934) (PMCID:PMC6292500)

Mitchell, Rebecca and Copland, Mhairi ORCID: https://orcid.org/0000-0002-7655-016X(2019)Defining niche interactions to target chronic myeloid leukemia stem cells. Haematologica, 105(1), pp. 2-4. (doi: 10.3324/haematol.2019.234898) (PMID:31894093) (PMCID:PMC6939514)

2018

Mitchell, R. et al. (2018)Targeting BCR-ABL independent TKI resistance in chronic myeloid leukaemia by mTOR and autophagy inhibition. Journal of the National Cancer Institute, 110(5), pp. 467-478. (doi: 10.1093/jnci/djx236) (PMID:29165716) (PMCID:PMC5946859)

2017

Ben Batalla, I. et al. (2017)Axl blockade by BGB324 inhibits BCR-ABL tyrosine kinase inhibitor-sensitive and -resistant chronic myeloid leukemia. Clinical Cancer Research, 23(9), pp. 2289-2300. (doi: 10.1158/1078-0432.CCR-16-1930) (PMID:27856601)

2016

Karvela, M. et al. (2016)ATG7 regulates energy metabolism, differentiation and survival of Philadelphia chromosome-positive cells. Autophagy, 12(6), pp. 936-948. (doi: 10.1080/15548627.2016.1162359) (PMID:27168493) (PMCID:PMC4922442)

This list was generated on Tue Feb 17 14:51:22 2026 GMT.